Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous n...
Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy
About this item
Full title
Author / Creator
Fiala, Ondrej , Pesek, Milos , Skrickova, Jana , Kolek, Vitezslav , Salajka, Frantisek , Tomiskova, Marcela , Satankova, Monika , Kultan, Juraj , Kuliskova, Jana , Svaton, Martin , Hrnciarik, Michal , Hejduk, Karel , Chloupkova, Renata , Topolcan, Ondrej , Hornychova, Helena , Nova, Marketa , Ryska, Ales and Finek, Jindrich
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Pemetrexed is an antifolate cytostatic agent targeting several folate-dependent enzymatic pathways, widely used in the treatment of locally advanced or metastatic stage non-small cell lung cancer. Aside from the non-squamous histology, there is still no available molecular biomarker predicting treatment efficacy of pemetrexed-based chemotherapy. Th...
Alternative Titles
Full title
Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a10b69b60ee9430d88da3e92872c1cd6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a10b69b60ee9430d88da3e92872c1cd6
Other Identifiers
ISSN
1010-4283
E-ISSN
1423-0380
DOI
10.1177/1010428317691186
